Arvinas, Inc. (ARVN)
7.46
+0.05
(+0.67%)
USD |
NASDAQ |
Oct 05, 16:00
7.46
0.00 (0.00%)
Pre-Market: 08:19
Arvinas Price : 7.46 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 7.46 | 7.505 | 7.22 | 7.46 | 628531.0 |
| Oct 02, 2026 | 7.51 | 7.52 | 7.30 | 7.41 | 585123.0 |
| Oct 01, 2026 | 7.74 | 7.82 | 7.43 | 7.43 | 807322.0 |
| Sep 30, 2026 | 7.55 | 8.04 | 7.442 | 7.735 | 1.061M |
| Sep 29, 2026 | 7.49 | 7.52 | 7.36 | 7.50 | 496059.0 |
| Sep 28, 2026 | 7.54 | 7.565 | 7.38 | 7.51 | 512105.0 |
| Sep 25, 2026 | 7.78 | 7.81 | 7.535 | 7.59 | 713363.0 |
| Sep 24, 2026 | 7.81 | 7.819 | 7.39 | 7.79 | 1.218M |
| Sep 23, 2026 | 8.60 | 8.64 | 7.815 | 7.83 | 761366.0 |
| Sep 22, 2026 | 8.37 | 8.57 | 8.30 | 8.51 | 685448.0 |
| Sep 21, 2026 | 8.37 | 8.44 | 8.21 | 8.30 | 639844.0 |
| Sep 18, 2026 | 8.29 | 8.35 | 8.190 | 8.29 | 1.776M |
| Sep 17, 2026 | 8.29 | 8.46 | 8.17 | 8.31 | 533211.0 |
| Sep 16, 2026 | 8.31 | 8.325 | 8.05 | 8.16 | 742625.0 |
| Sep 15, 2026 | 8.34 | 8.385 | 8.09 | 8.26 | 2.523M |
| Sep 14, 2026 | 8.49 | 8.70 | 8.39 | 8.40 | 1.472M |
| Sep 11, 2026 | 8.82 | 8.915 | 8.365 | 8.45 | 908559.0 |
| Sep 10, 2026 | 8.67 | 8.775 | 8.47 | 8.71 | 776727.0 |
| Sep 09, 2026 | 9.085 | 9.10 | 8.75 | 8.76 | 738471.0 |
| Sep 08, 2026 | 9.23 | 9.34 | 8.97 | 9.08 | 570720.0 |
| Sep 04, 2026 | 9.31 | 9.455 | 9.22 | 9.39 | 449299.0 |
| Sep 03, 2026 | 9.68 | 9.691 | 9.21 | 9.31 | 501476.0 |
| Sep 02, 2026 | 9.28 | 9.64 | 9.27 | 9.59 | 548800.0 |
| Sep 01, 2026 | 9.14 | 9.30 | 9.060 | 9.28 | 491141.0 |
| Aug 31, 2026 | 9.12 | 9.27 | 8.960 | 9.20 | 659720.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.11 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Fulcrum Therapeutics, Inc. | 3.71 |
| Definium Therapeutics, Inc. | 36.23 |
| LeonaBio, Inc. | 5.58 |
Price Related Metrics
| PE Ratio | 46.51 |
| PS Ratio | 1.577 |
| Price to Book Value | 0.8665 |
| Earnings Yield | 2.15% |
| Market Cap | 487.14M |
| Normalized PE Ratio | 34.10 |